Search results
Green hydrogen producer signs first-of-its-kind agreement with major steel company: 'Increasingly...
The Cool Down via Yahoo News· 5 days agoIt's exciting to see a leading steel company like Ugitech, which produces 220,000 tons of steel each...
Council Post: Embracing Advanced Tech In The Food And Beverage Industry, Part 3: Becoming...
Forbes· 1 day agoGary Iles is the senior vice president of marketing and business development at TraceGains. For food...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
KOLR - KSFX Ozarks· 4 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoPhase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThat RS Rating means Pfizer stock ranks in the bottom 22% of all stocks in terms of performance over...
Last remaining Second World War escort ship risks being scrapped
Daily Telegraph· 2 days agoThe last remaining Second World War escort ship risks being scrapped unless £150,000 can be raised...
Battery packs, dry ice and camping stoves: Tips from D-FW residents on power outages
Dallas Morning News· 5 days agoAbout 125,000 Oncor customers were without power Friday in the Dallas area, down from the nearly...
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 4 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO ...
The problems with the middle class and ketamine therapy
Market Watch· 3 days agoToday, Venessa comes on the show and explains why the inflation shock of recent years put the final...